A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma (Q40070152)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma |
scientific article |
Statements
1 reference
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma (English)
1 reference
Ahmed FY
1 reference
Leonard GA
1 reference
A'Hern R
1 reference
Taylor AE
1 reference
Lorentzos A
1 reference
Atkinson H
1 reference
Moore J
1 reference
Nicolson MC
1 reference
Riches PG
1 reference
Gore ME
1 reference
1 October 1996
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference